척수강내 펌프 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 용도별, 지역별, 부문 예측(2024-2030년)

Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide), By Application (Pain, Spasticity), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,311,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,708,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,502,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

척수강내 펌프 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 척수강내 펌프 시장 규모는 2030년에 5억 1,330만 달러에 달하며, 2024-2030년 CAGR 5.3%로 성장할 것으로 예측됩니다.

보다 빠른 통증 완화를 위해 척수에 약물을 신속하게 전달하기 위한 첨단 척수강내 펌프에 대한 수요가 증가함에 따라 예측 기간 중 산업 성장을 가속할 것으로 예상됩니다. 척수강내 펌프와 관련된 이점은 산업 성장을 강화할 것으로 예상됩니다. 척수강내 투여 펌프를 통해 오피오이드와 같은 약물을 투여하면 진통 효과가 뛰어날 뿐만 아니라 부작용을 줄일 수 있습니다. 또한 통증 펌프는 정제로 복용하는 약물의 양에 비해 소량만 복용하면 되므로 개인들 사이에서 선호도가 높아지고 있습니다.

약물전달 시스템은 효과적인 통증 완화, 높은 환자 만족도, 경구용 약물에 비해 부작용 감소, 진통제 사용량 감소 등 많은 이점을 제공합니다. 또한 이 치료법은 지시대로 사용하면 효과적이고 안전하며, 필요에 따라 용량을 조절하여 맞춤화할 수 있습니다. 따라서 표적 약물전달 시스템에 대한 수요가 증가함에 따라 산업 성장을 가속할 것으로 예상됩니다. 방광내 카테터와 관련된 합병증은 산업 성장을 저해하고 있습니다. 카테터가 막히거나 찢어지거나 절단되면 척수강내 카테터 고장으로 인해 척수강내 약물 투여가 갑자기 중단될 수 있습니다. 또한 약물전달 장비와 관련된 부작용의 대부분은 방광내 카테터 고장으로 인해 발생합니다.

척수강내 펌프 시장 보고서 하이라이트

• 몰핀 유형은 대량 경구용 오피오이드에 비해 저용량으로 진통 효과를 얻을 수 있고 체계적 부작용이 적어 2023년 가장 큰 매출 점유율을 차지했습니다.
• 통증 용도는 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 이는 통증 관련 질환의 치료 효율을 높인 첨단 척수강내 펌프가 개발되었기 때문입니다.
• 북미는 2023년 가장 큰 매출 점유율을 차지할 것으로 예상되며, 예측 기간 중에도 지배적인 위치를 유지할 것으로 예상됩니다.
• 이는 만성 요통의 높은 유병률과 미국, 캐나다 등의 국가에서 연구개발 비용이 증가하고 있기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 척수강내 펌프 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 척수강내 펌프 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 척수강내 펌프 시장 : 유형별 추정·동향 분석

• 부문 대시보드
• 척수강내 펌프 시장 : 유형별 변동 분석
• 척수강내 펌프 시장 : 유형별 전망
• 2018-2030년 시장 규모와 예측 및 동향 분석
• Baclofen
• Bupivacaine
• Clonidine
• Morphine
• Ziconotide
• 기타

제5장 척수강내 펌프 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 척수강내 펌프 시장 : 용도별 변동 분석
• 용도별 척수강내 펌프 시장 전망
• 2018-2030년 시장 규모와 예측 및 동향 분석
• 경직
• 통증

제6장 척수강내 펌프 시장 : 지역별 추정·동향 분석

• 지역 대시보드
• 지역별 척수강내 펌프 시장변수 분석
• 척수강내 펌프 시장 : 유형과 용도별 지역 추정·동향 분석
• 2018-2030년 시장 규모와 예측 및 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 시장 참여 기업의 분류
• 주요 기업 개요
  • Medtronic plc
  • Tricumed GmbH
  • Arrow International
  • Codman &Shurtleff
  • Medallion Therapeutics
  • Flowonix
  • Smith's Medical
  • Teleflex Incorporated

KSA

영문 목차

영문목차

Intrathecal Pumps Market Growth & Trends:

The global intrathecal pumps market size is expected to reach at USD 513.3 million in 2030 and is projected to grow at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for advanced intrathecal pumps for rapid delivery of medications into the spinal cord for faster pain relief is expected to boost the industry's growth during the forecast period.The advantages associated with intrathecal pumps are anticipated to augment the industry growth. Medications, such as opioids, when given through an intrathecal pain pump give superior pain relief as well as reduce side effects. Also, a small amount of medication is required in pain pumps as compared to the amount of medication taken in pill form, thereby increasing its preference among individuals.

The drug delivery therapy systems offer numerous benefits, such as effective pain relief, high patient satisfaction, reduced side effects compared to oral medication, and reduced use of pain medication. In addition, this treatment is effective and safe when used as directed and can be customized by varying the dosage as per need. Hence, rising demand for targeted drug delivery systems is expected to boost industry growth.The complications associated with the intrathecal catheter are creating hindrance in the industry growth. Occlusion, lacerations, and disconnection of the catheter cause a sudden cessation of intrathecal drug administration due to intrathecal catheter failure. Also, the majority of drug delivery device-related adverse events occurdue to the failure of the intrathecal catheter.

Intrathecal Pumps Market Report Highlights:

• The morphine type segment held the largest revenue share in 2023 as intrathecal morphine receives analgesic effect at a lower dose with less systematic side effects as compared to large dose oral opioids.
• The pain application segment is expected to grow at the fastest CAGR during the forecast period
• This is owing to the development of advanced intrathecal pumps having enhanced efficiency in treating pain-related disorders
• North America accounted for the largest revenue share in 2023 and is projected to maintain its dominant position throughout the forecast years
• This is attributed to the high prevalence of chronic back pain and increased R&D expenditure in countries, such as the U.S. and Canada

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Intrathecal Pumps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic back pain and muscle spasticity
    • 3.2.1.2. Increasing demand for targeted drug delivery systems
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Technological and surgical complications
• 3.3. Intrathecal Pumps Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Intrathecal Pumps Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Intrathecal Pumps Market: Type Movement Analysis
• 4.3. Intrathecal Pumps Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Baclofen
  • 4.5.1. Baclofen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Bupivacaine
  • 4.6.1. Bupivacaine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Clonidine
  • 4.7.1. Clonidine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Morphine
  • 4.8.1. Morphine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Ziconotide
  • 4.9.1. Ziconotide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intrathecal Pumps Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Intrathecal Pumps Market: Application Movement Analysis
• 5.3. Intrathecal Pumps Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Spasticity
  • 5.5.1. Spasticity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Pain
  • 5.6.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intrathecal Pumps Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Intrathecal Pumps Market movement analysis
• 6.3. Intrathecal Pumps Market: Regional Estimates & Trend Analysis by Type & Application
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. UK Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Germany Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. France Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Italy Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Spain Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Denmark Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Sweden Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Reimbursement scenario
    • 6.6.9.5. Norway Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Japan Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. China Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. India Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Australia Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Thailand Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Brazil Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Argentina Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. South Africa Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. Saudi Arabia Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. UAE Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Reimbursement scenario
    • 6.9.5.5. Kuwait Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic plc
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Type benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Tricumed GmbH
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Type benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Arrow International
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Type benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Codman & Shurtleff
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Type benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Medallion Therapeutics
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Type benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Flowonix
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Type benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Smith's Medical
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Type benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Teleflex Incorporated
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Type benchmarking
    • 7.2.8.4. Strategic initiatives

관련자료